Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000251.3(MSH2):c.1662-12_1677delTTCGATTTGCAGCAAATTGACTTCTTTA(p.Ser554fs) variant causes a frameshift, splice acceptor, splice region, intron change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-47470952-TTTCGATTTGCAGCAAATTGACTTCTTTA-T is Pathogenic according to our data. Variant chr2-47470952-TTTCGATTTGCAGCAAATTGACTTCTTTA-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 220243.Status of the report is criteria_provided_single_submitter, 1 stars.
Review Status: criteria provided, single submitter
Collection Method: clinical testing
For these reasons, this variant has been classified as Likely Pathogenic. While this particular variant has not been reported in the literature, truncating variants in MSH2 are known to be pathogenic (PMID: 15849733, 24362816). The region deleted by this variant includes the acceptor splice site in intron 10 of the MSH2 gene, which could result in the out-of-frame skipping of exon 11. However, this prediction has not been confirmed by published transcriptional studies. This sequence change deletes the last 12 nucleotides in intron 10 and the first 16 nucleotides in exon 11 of the MSH2 mRNA (c.1662-12_1677delTTCGATTTGCAGCAAATTGACTTCTTTA). It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. -